Search - tctmd.com

Displaying 1 - 20 of 125

Sort: Relevancy | Date

News Daily News

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Michael O'Riordan

December 03, 2018

News Features

Bruises and Bumps: How Cardiology Meetings Survived the End of Direct Industry Sponsorship in Europe

Todd Neale

November 30, 2018

News Daily News

Metoclopramide May Mute Morphine’s Hampering of Ticagrelor Efficacy

Caitlin E. Cox

November 28, 2018

News Daily News

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

L.A. McKeown

November 27, 2018

News Daily News

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Michael O'Riordan

November 20, 2018

Presentation TCT Abstracts Posters 2018

Impact of contrast injection on intracoronary pressure during optical coherence tomography imaging

Presenter: Kunihiro Shimamura

November 16, 2018

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

News Daily News

Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab

Yael L. Maxwell

November 14, 2018

News Conference News AHA 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Michael O'Riordan

November 11, 2018

News Conference News AHA 2018

T-Time: Alteplase Infusion No Help for Failed Reperfusion in STEMI PCI

Shelley Wood

November 11, 2018

News Conference News AHA 2018

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

Todd Neale

November 10, 2018

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Daily News

Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows

Michael O'Riordan

November 06, 2018

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Shelley Wood

November 05, 2018

News Daily News

European Guidelines Represent First Intersocietal Position on Percutaneous PFO Closure

Yael L. Maxwell

November 01, 2018

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

News Daily News

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

Michael O'Riordan

October 25, 2018

News Opinion Fellow Talk

A Look Back at TCT 2018: What I Took Away From the Meeting

Yashasvi Chugh, MD

October 23, 2018

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Daily News

Isolated SAVR Volumes Slide as TAVR Numbers Mount in the US

Yael L. Maxwell

October 19, 2018

Advertisement

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Bruises and Bumps: How Cardiology Meetings Survived the End of Direct Industry Sponsorship in Europe

Metoclopramide May Mute Morphine’s Hampering of Ticagrelor Efficacy

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Impact of contrast injection on intracoronary pressure during optical coherence tomography imaging

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

T-Time: Alteplase Infusion No Help for Failed Reperfusion in STEMI PCI

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

European Guidelines Represent First Intersocietal Position on Percutaneous PFO Closure

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

A Look Back at TCT 2018: What I Took Away From the Meeting

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Isolated SAVR Volumes Slide as TAVR Numbers Mount in the US

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content